Mansfield Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.17 M
- Company Age 35 Year, 7 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 0.28 M
- Revenue Growth -3.38%
- Profit Growth -40.54%
- Ebitda -40.76%
- Net Worth 8.27%
- Total Assets -15.94%
About Mansfield Laboratories
Mansfield Laboratories Private Limited (MLPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 June 1989 and has a history of 35 years and seven months. Its registered office is in Uttar Pradesh, Uttar Pradesh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.17 M.
The company currently has active open charges totaling ₹0.28 M.
Madhu Agrawal, Alok Agarwal, and Anupriya Agrawal serve as directors at the Company.
Company Details
- LocationUttar Pradesh, Uttar Pradesh
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24236UP1989PTC010811
- Company No.
010811
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 1989
- Date of AGM
30 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Mansfield Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhu Agrawal  | Director | 01-Jun-1989 | Current |
Alok Agarwal  | Additional Director | 29-Mar-2008 | Current |
| Anupriya Agrawal | Director | 14-Aug-2000 | Current |
Financial Performance of Mansfield Laboratories.
Mansfield Laboratories Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 3.38% decrease. The company also saw a substantial fall in profitability, with a 40.54% decrease in profit. The company's net worth moved up by a moderate rise of 8.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mansfield Laboratories?
In 2017, Mansfield Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.28 M
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jan 2000 | Indian Overseas Bank | ₹0.20 M | Open |
| 28 Dec 1993 | Indian Overseas Bank | ₹0.05 M | Open |
| 22 Jun 1992 | Indian Overseas Bank | ₹0.03 M | Open |
How Many Employees Work at Mansfield Laboratories?
Unlock and access historical data on people associated with Mansfield Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mansfield Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mansfield Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
